Vaccines Can Play Vital Role In Addressing AMR, Wellcome Policy Director Says

Wellcome: Vaccines work — for superbugs too
Ed Whiting, director of policy and chief of staff at Wellcome, discusses the role of vaccines in addressing the threat of antimicrobial resistance (AMR), writing, “Discovering new antibiotics to replace those that no longer work is essential, but if we could use vaccines (already saving two to three million lives a year) to prevent the spread of infections in the first place we could save many more lives. … This is a really exciting opportunity for both the AMR and vaccines communities to work together on one of the world’s most pressing global health challenges. Vaccines are our first lines of defense against a huge number of health problems — and they can be for superbugs as well” (3/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.